Canadian Myeloma Research Group (“CMRG”) is a federally incorporated, non-profit research organization, located in Ontario Canada, with the purpose of supporting and/or conducting of basic, translational, and clinical research to develop new or improved products and processes for the diagnosis, prognosis, treatment, and cure of multiple myeloma. In efforts to achieve this goal, CMRG may engage, collaborate, or associate with you. During this association with CRMG, you may come in contact with confidential information, confidential records and goods (written, electronic and verbal) that are the property of CMRG or its business partners.
As used herein, “information” shall mean proprietary and/or confidential technical, business, clinical, scientific, or other confidential information disclosed by CMRG which is designated as being confidential non-public information. This includes, without limitation, information relating to CMRG’s research and development projects, plans, and procedures regarding the field of multiple myeloma and related disorders. This information must be kept confidential and is not for public information. No records, documents or information are to be removed from CMRG or shared with anyone without the permission of the CMRG central office.
You understand and promise that no records or documents are to be removed from CMRG or shared with anyone without a written permission from the CMRG management. A breach of this agreement will be taken very seriously and result in repercussions up to and including possible legal action against you by CMRG. As a member, you may view or download CMRG confidential information and/or documents for your own use only.
By registering for the CMRG Research Portal, you agree to the following:
Only fill in if you are not human
CMRG positions itself at the heart of myeloma research in Canada with the creation of national clinical trials, database and correlative research platforms.
Our quarterly newsletter keeps our community informed and engaged with CMRG’s progress and future initiatives.